id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-D-1138-0153,FDA,FDA-2020-D-1138,Effects of the COVID–19 Public Health Emergency on Formal Meetings and User Fee Applications for Medical Devices—Questions and Answers (Revised); Withdrawal of Guidance,Notice,Withdrawal,2022-06-07T04:00:00Z,2022,6,2022-06-07T04:00:00Z,,2022-06-07T14:27:51Z,2022-12176,0,0,09000064851456f2
FDA-2020-D-1138-0152,FDA,FDA-2020-D-1138,Supplements for Approved Premarket Approval (PMA) or Humanitarian Device Exemption (HDE) Submissions During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (Revised),Other,Guidance,2022-05-04T04:00:00Z,2022,5,2022-05-04T04:00:00Z,,2024-11-12T23:41:02Z,,1,0,090000648504d501
FDA-2020-D-1138-0149,FDA,FDA-2020-D-1138,Guidance Documents Related to Coronavirus Disease 2019; Availability,Notice,Notice of Availability,2022-01-21T05:00:00Z,2022,1,2022-01-21T05:00:00Z,,2022-01-21T13:45:27Z,2022-01146,0,0,0900006484f2c31e
FDA-2020-D-1138-0150,FDA,FDA-2020-D-1138,"Enforcement Policy for Viral Transport Media During the Coronavirus Disease (COVID–19) Public Health Emergency (Revised); Guidance for Commercial Manufacturers, Clinical Laboratories, and Food and Drug Administration Staff",Other,Guidance,2022-01-21T05:00:00Z,2022,1,2022-01-21T05:00:00Z,2023-11-08T04:59:59Z,2023-05-24T21:14:35Z,,0,0,0900006484f2d339